BioSpace News Archive

Four member agencies of Vermont Care Partners (VCP) have come together to reshape the delivery and coordination of care through a partnership with Netsmart to deploy a unified technology platform.

Arista Cereal Technologies Pty Ltd (ARISTA) announces that the lawsuit initiated by Arcadia Biosciences Inc. against ARISTA in the District Court for the Southern District of New York (SDNY) has been dismissed.

Medline today announced its prime vendor distribution agreement with Oregon-based Strategic Resource Partners (SRP), a regional group of Intalere National Health Alliance (INHA).

Creative Peptides, one of the world’s leading peptide suppliers, announced to offer Peptide Analysis services for researchers in the biopharmaceutical industry.

The Alliance to Fight the 40|Don’t Tax My Health Care, a broad-based coalition committed to repealing the 40 percent tax on employer-sponsored health benefits – the so-called “Cadillac Tax” – applauds Rep. Joe Courtney (D-CT), Rep. Mike Kelly (R-PA), Rep. Suzan DelBene (D-WA), and Rep. Elise Stefanik (R-NY), for their bipartisan reintroduction of legislation

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced financial results for the three and six months ended December 31, 2018.

Immunomic Therapeutics announced today that its’ founder and CEO, William Hearl, Ph.D., will present an overview of the company and its UNITE technology platform at the 2019 BIO CEO & Investor Conference on February 12, 2019 at 2:00 pm EST in the Hudson/Empire Room at the Marriott Marquis in New York City.

The immunoassay company Mercodia is launching a new assay for detection of the insulin analog Lispro.

DexCom (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019.

UK patients with N. gonorrhoeae (GC) now have the option of receiving the cheap and easily-administered oral antibiotic ciprofloxacin thanks to updated treatment guidelines and the availability of a novel molecular diagnostic and antimicrobial susceptibility test (AST).